| scholarly article | Q13442814 |
| P50 | author | Ron Fouchier | Q59210534 |
| Saskia L Smits | Q89297289 | ||
| Erhard van der Vries | Q92632474 | ||
| Koert J Stittelaar | Q104743596 | ||
| Martin Schutten | Q115215207 | ||
| P2093 | author name string | Geert van Amerongen | |
| Rueshandra Roosenhoff | |||
| Anne van der Linden | |||
| P2860 | cites work | Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child | Q79364184 |
| Neuraminidase inhibitors for preventing and treating influenza in adults and children | Q24197463 | ||
| Prolonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferrets | Q27334946 | ||
| Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance | Q28282405 | ||
| Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial | Q28475986 | ||
| Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses | Q28541953 | ||
| Low dose influenza virus challenge in the ferret leads to increased virus shedding and greater sensitivity to oseltamivir. | Q30361125 | ||
| Severity of clinical disease and pathology in ferrets experimentally infected with influenza viruses is influenced by inoculum volume. | Q30366406 | ||
| Antiviral combinations for severe influenza. | Q30366719 | ||
| Identification of amino acid substitutions supporting antigenic change of influenza A(H1N1)pdm09 viruses. | Q30370987 | ||
| Prolonged shedding of influenza A(H1N1)v virus: two case reports from France 2009. | Q30383373 | ||
| Oseltamivir-resistant pandemic (H1N1) 2009 influenza in a severely ill patient: the first Australian case. | Q30385172 | ||
| Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection | Q30388857 | ||
| Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study | Q30391256 | ||
| Influenza antivirals currently in late-phase clinical trial | Q30398099 | ||
| Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients | Q30400403 | ||
| Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives | Q30410899 | ||
| Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods | Q30412663 | ||
| Comparison of temporal and spatial dynamics of seasonal H3N2, pandemic H1N1 and highly pathogenic avian influenza H5N1 virus infections in ferrets | Q30420448 | ||
| Molecular assays for quantitative and qualitative detection of influenza virus and oseltamivir resistance mutations | Q30429575 | ||
| Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. | Q30452889 | ||
| Permissive secondary mutations enable the evolution of influenza oseltamivir resistance | Q34118992 | ||
| Selecting vaccine strains for H3N2 human influenza A virus | Q35350500 | ||
| Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus | Q35758840 | ||
| Oseltamivir shortens hospital stays of critically ill children hospitalized with seasonal influenza: a retrospective cohort study | Q36186832 | ||
| Association of Oseltamivir Treatment With Virus Shedding, Illness, and Household Transmission of Influenza Viruses | Q36899991 | ||
| How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation | Q36965855 | ||
| Ferrets as a Novel Animal Model for Studying Human Respiratory Syncytial Virus Infections in Immunocompetent and Immunocompromised Hosts | Q37049972 | ||
| The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts. | Q37411707 | ||
| Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses | Q37416103 | ||
| End points for testing influenza antiviral treatments for patients at high risk of severe and life-threatening disease | Q37737726 | ||
| Viral infections in immunocompromised patients | Q37824989 | ||
| Antivirals and resistance: influenza virus | Q37996227 | ||
| Early oseltamivir treatment of influenza in children 1-3 years of age: a randomized controlled trial | Q38500366 | ||
| Enrichment by hybridisation of long DNA fragments for Nanopore sequencing | Q38635837 | ||
| Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2017-18 Influenza Season | Q40070473 | ||
| Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets | Q40580607 | ||
| Peramivir is as effective as oral oseltamivir in the treatment of severe seasonal influenza | Q40970018 | ||
| Treatment of Immunocompromised, Critically Ill Patients with Influenza A H1N1 Infection with a Combination of Oseltamivir, Amantadine, and Zanamivir. | Q41011707 | ||
| Oseltamivir inhibits influenza virus replication and transmission following ocular-only aerosol inoculation of ferrets | Q41123104 | ||
| Antiviral activity of novel oseltamivir derivatives against some influenza virus strains. | Q41743519 | ||
| Viral shedding and susceptibility to oseltamivir in hospitalized immunocompromised patients with influenza in the Influenza Resistance Information Study (IRIS). | Q42150236 | ||
| Factors associated with early hospital discharge of adult influenza patients. | Q43176079 | ||
| Viral loads and duration of viral shedding in adult patients hospitalized with influenza. | Q43873120 | ||
| In vitro and in vivo activities of T-705 and oseltamivir against influenza virus | Q44705790 | ||
| Global assessment of resistance to neuraminidase inhibitors, 2008-2011: the Influenza Resistance Information Study (IRIS). | Q44805348 | ||
| Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). | Q45152293 | ||
| Outcome of influenza infection managed with oseltamivir in lung transplant recipients | Q46700589 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e0200849 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Influenza A/H3N2 virus infection in immunocompromised ferrets and emergence of antiviral resistance | |
| P478 | volume | 13 |
| Q90325454 | Viral Kinetics and Resistance Development in Children Treated with Neuraminidase Inhibitors: The Influenza Resistance Information Study (IRIS) | cites work | P2860 |
Search more.